IN202141039393A - - Google Patents
Download PDFInfo
- Publication number
- IN202141039393A IN202141039393A IN202141039393A IN202141039393A IN202141039393A IN 202141039393 A IN202141039393 A IN 202141039393A IN 202141039393 A IN202141039393 A IN 202141039393A IN 202141039393 A IN202141039393 A IN 202141039393A IN 202141039393 A IN202141039393 A IN 202141039393A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202141039393A IN202141039393A (https=) | 2021-08-31 | 2021-08-31 | |
| CA3229559A CA3229559A1 (en) | 2021-08-31 | 2022-08-30 | Novel crystalline polymorph of lurbinectedin and improved process for the preparation of lurbinectedin |
| US18/686,936 US20240352039A1 (en) | 2021-08-31 | 2022-08-30 | Novel crystalline polymorph of lurbinectedin and improved process for the preparation of lurbinectedin |
| PCT/IN2022/050772 WO2023031960A1 (en) | 2021-08-31 | 2022-08-30 | Novel crystalline polymorph of lurbinectedin and improved process for the preparation of lurbinectedin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202141039393A IN202141039393A (https=) | 2021-08-31 | 2021-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN202141039393A true IN202141039393A (https=) | 2023-03-03 |
Family
ID=85412216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN202141039393A IN202141039393A (https=) | 2021-08-31 | 2021-08-31 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240352039A1 (https=) |
| CA (1) | CA3229559A1 (https=) |
| IN (1) | IN202141039393A (https=) |
| WO (1) | WO2023031960A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025059336A1 (en) * | 2023-09-13 | 2025-03-20 | Navinta, Llc | An improved process for preparation of lurbinectedin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0119243D0 (en) * | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
| MA56827B2 (fr) * | 2019-11-21 | 2023-09-27 | Pharma Mar Sa | Procédés de traitement du cancer du poumon à petites cellules avec des formulations de lurbinectédine |
-
2021
- 2021-08-31 IN IN202141039393A patent/IN202141039393A/en unknown
-
2022
- 2022-08-30 US US18/686,936 patent/US20240352039A1/en active Pending
- 2022-08-30 WO PCT/IN2022/050772 patent/WO2023031960A1/en not_active Ceased
- 2022-08-30 CA CA3229559A patent/CA3229559A1/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025059336A1 (en) * | 2023-09-13 | 2025-03-20 | Navinta, Llc | An improved process for preparation of lurbinectedin |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240352039A1 (en) | 2024-10-24 |
| WO2023031960A1 (en) | 2023-03-09 |
| CA3229559A1 (en) | 2023-03-09 |